Global Medicated Lip Balms 麻豆原创 Research Report 2023

Publication ID:

PB504231683

Publication Date:

April 20, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Retailing [2]

Consumer & Retail [3]

Description:

Medicated Lip Balm helps prevent dryness and chapping.
Highlights
The global Medicated Lip Balms market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Medicated Lip Balms is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Medicated Lip Balms is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Medicated Lip Balms include L'Or茅al S.A., Revlon, Pfizer, Kao Corporation, Avon Products, Inc., The Himalaya Drug Company, Beiersdorf AG., Bayer Corporation and Blistex Inc., etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Medicated Lip Balms, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medicated Lip Balms.
The Medicated Lip Balms market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Medicated Lip Balms market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medicated Lip Balms manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
L'Or茅al S.A.
Revlon
Pfizer
Kao Corporation
Avon Products, Inc.
The Himalaya Drug Company
Beiersdorf AG.
Bayer Corporation
Blistex Inc.
Segment by Type
Male
Female
Segment by Application
Online
Offline
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Medicated Lip Balms manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Medicated Lip Balms in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Medicated Lip Balms 麻豆原创 Overview
1.1 Product Overview and Scope of Medicated Lip Balms
1.2 Medicated Lip Balms Segment by Type
1.2.1 Global Medicated Lip Balms 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 Male
1.2.3 Female
1.3 Medicated Lip Balms Segment by Application
1.3.1 Global Medicated Lip Balms 麻豆原创 Value by Application: (2023-2029)
1.3.2 Online
1.3.3 Offline
1.4 Global Medicated Lip Balms 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Medicated Lip Balms Revenue 2018-2029
1.4.2 Global Medicated Lip Balms Sales 2018-2029
1.4.3 Global Medicated Lip Balms 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Medicated Lip Balms 麻豆原创 Competition by Manufacturers
2.1 Global Medicated Lip Balms Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Medicated Lip Balms Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Medicated Lip Balms Average Price by Manufacturers (2018-2023)
2.4 Global Medicated Lip Balms Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Medicated Lip Balms, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medicated Lip Balms, Product Type & Application
2.7 Medicated Lip Balms 麻豆原创 Competitive Situation and Trends
2.7.1 Medicated Lip Balms 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Medicated Lip Balms Players 麻豆原创 Share by Revenue
2.7.3 Global Medicated Lip Balms 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Medicated Lip Balms Retrospective 麻豆原创 Scenario by Region
3.1 Global Medicated Lip Balms 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Medicated Lip Balms Global Medicated Lip Balms Sales by Region: 2018-2029
3.2.1 Global Medicated Lip Balms Sales by Region: 2018-2023
3.2.2 Global Medicated Lip Balms Sales by Region: 2024-2029
3.3 Global Medicated Lip Balms Global Medicated Lip Balms Revenue by Region: 2018-2029
3.3.1 Global Medicated Lip Balms Revenue by Region: 2018-2023
3.3.2 Global Medicated Lip Balms Revenue by Region: 2024-2029
3.4 North America Medicated Lip Balms 麻豆原创 Facts & Figures by Country
3.4.1 North America Medicated Lip Balms 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Medicated Lip Balms Sales by Country (2018-2029)
3.4.3 North America Medicated Lip Balms Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Medicated Lip Balms 麻豆原创 Facts & Figures by Country
3.5.1 Europe Medicated Lip Balms 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Medicated Lip Balms Sales by Country (2018-2029)
3.5.3 Europe Medicated Lip Balms Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medicated Lip Balms 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Medicated Lip Balms 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Medicated Lip Balms Sales by Country (2018-2029)
3.6.3 Asia Pacific Medicated Lip Balms Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Medicated Lip Balms 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Medicated Lip Balms 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Medicated Lip Balms Sales by Country (2018-2029)
3.7.3 Latin America Medicated Lip Balms Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Medicated Lip Balms 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Medicated Lip Balms 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Medicated Lip Balms Sales by Country (2018-2029)
3.8.3 Middle East and Africa Medicated Lip Balms Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medicated Lip Balms Sales by Type (2018-2029)
4.1.1 Global Medicated Lip Balms Sales by Type (2018-2023)
4.1.2 Global Medicated Lip Balms Sales by Type (2024-2029)
4.1.3 Global Medicated Lip Balms Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Medicated Lip Balms Revenue by Type (2018-2029)
4.2.1 Global Medicated Lip Balms Revenue by Type (2018-2023)
4.2.2 Global Medicated Lip Balms Revenue by Type (2024-2029)
4.2.3 Global Medicated Lip Balms Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Medicated Lip Balms Price by Type (2018-2029)
5 Segment by Application
5.1 Global Medicated Lip Balms Sales by Application (2018-2029)
5.1.1 Global Medicated Lip Balms Sales by Application (2018-2023)
5.1.2 Global Medicated Lip Balms Sales by Application (2024-2029)
5.1.3 Global Medicated Lip Balms Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global Medicated Lip Balms Revenue by Application (2018-2029)
5.2.1 Global Medicated Lip Balms Revenue by Application (2018-2023)
5.2.2 Global Medicated Lip Balms Revenue by Application (2024-2029)
5.2.3 Global Medicated Lip Balms Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global Medicated Lip Balms Price by Application (2018-2029)
6 Key Companies Profiled
6.1 L'Or茅al S.A.
6.1.1 L'Or茅al S.A. Corporation Information
6.1.2 L'Or茅al S.A. Description and Business Overview
6.1.3 L'Or茅al S.A. Medicated Lip Balms Sales, Revenue and Gross Margin (2018-2023)
6.1.4 L'Or茅al S.A. Medicated Lip Balms Product Portfolio
6.1.5 L'Or茅al S.A. Recent Developments/Updates
6.2 Revlon
6.2.1 Revlon Corporation Information
6.2.2 Revlon Description and Business Overview
6.2.3 Revlon Medicated Lip Balms Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Revlon Medicated Lip Balms Product Portfolio
6.2.5 Revlon Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Medicated Lip Balms Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Pfizer Medicated Lip Balms Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Kao Corporation
6.4.1 Kao Corporation Corporation Information
6.4.2 Kao Corporation Description and Business Overview
6.4.3 Kao Corporation Medicated Lip Balms Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Kao Corporation Medicated Lip Balms Product Portfolio
6.4.5 Kao Corporation Recent Developments/Updates
6.5 Avon Products, Inc.
6.5.1 Avon Products, Inc. Corporation Information
6.5.2 Avon Products, Inc. Description and Business Overview
6.5.3 Avon Products, Inc. Medicated Lip Balms Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Avon Products, Inc. Medicated Lip Balms Product Portfolio
6.5.5 Avon Products, Inc. Recent Developments/Updates
6.6 The Himalaya Drug Company
6.6.1 The Himalaya Drug Company Corporation Information
6.6.2 The Himalaya Drug Company Description and Business Overview
6.6.3 The Himalaya Drug Company Medicated Lip Balms Sales, Revenue and Gross Margin (2018-2023)
6.6.4 The Himalaya Drug Company Medicated Lip Balms Product Portfolio
6.6.5 The Himalaya Drug Company Recent Developments/Updates
6.7 Beiersdorf AG.
6.6.1 Beiersdorf AG. Corporation Information
6.6.2 Beiersdorf AG. Description and Business Overview
6.6.3 Beiersdorf AG. Medicated Lip Balms Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Beiersdorf AG. Medicated Lip Balms Product Portfolio
6.7.5 Beiersdorf AG. Recent Developments/Updates
6.8 Bayer Corporation
6.8.1 Bayer Corporation Corporation Information
6.8.2 Bayer Corporation Description and Business Overview
6.8.3 Bayer Corporation Medicated Lip Balms Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Bayer Corporation Medicated Lip Balms Product Portfolio
6.8.5 Bayer Corporation Recent Developments/Updates
6.9 Blistex Inc.
6.9.1 Blistex Inc. Corporation Information
6.9.2 Blistex Inc. Description and Business Overview
6.9.3 Blistex Inc. Medicated Lip Balms Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Blistex Inc. Medicated Lip Balms Product Portfolio
6.9.5 Blistex Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medicated Lip Balms Industry Chain Analysis
7.2 Medicated Lip Balms Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medicated Lip Balms Production Mode & Process
7.4 Medicated Lip Balms Sales and 麻豆原创ing
7.4.1 Medicated Lip Balms Sales Channels
7.4.2 Medicated Lip Balms Distributors
7.5 Medicated Lip Balms Customers
8 Medicated Lip Balms 麻豆原创 Dynamics
8.1 Medicated Lip Balms Industry Trends
8.2 Medicated Lip Balms 麻豆原创 Drivers
8.3 Medicated Lip Balms 麻豆原创 Challenges
8.4 Medicated Lip Balms 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

L'Or茅al S.A.
Revlon
Pfizer
Kao Corporation
Avon Products, Inc.
The Himalaya Drug Company
Beiersdorf AG.
Bayer Corporation
Blistex Inc.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.